Philip Friedlander

Search results

• Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai

  Marron, T., Friedlander, P. & Bhardwaj, N.

  21/03/25

  70 items of Media coverage

  Press/Media

• Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai

  Marron, T., Friedlander, P. & Bhardwaj, N.

  21/03/25

  1 item of Media coverage

  Press/Media

• Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai

  Marron, T., Friedlander, P. & Bhardwaj, N.

  17/03/25

  2 items of Media coverage

  Press/Media

• Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai

  Marron, T., Friedlander, P. & Bhardwaj, N.

  17/03/25

  1 item of Media coverage

  Press/Media

• Dana-Farber Cancer Institute Researchers Release New Study Findings on Cancer Gene Therapy (Phase II trial of vaccination with autologous, irradiated melanoma cells engineered by adenoviral mediated gene transfer to secrete ...)

  Friedlander, P.

  27/05/24

  1 item of Media coverage

  Press/Media

• Studies from Icahn School of Medicine at Mount Sinai Further Understanding of Squamous Cell Carcinoma (Case report: Regression of in-transit metastases of cutaneous squamous cell carcinoma with combination pembrolizumab and topical diphencyprone)

  Friedlander, P. & Gulati, N.

  23/05/24

  1 item of Media coverage

  Press/Media

• Study Data from Mount Sinai School of Medicine Update Understanding of Melanoma (Preclinical Activity of 4-demethyl-4-cholesteryloxycarbonylpenclomedine In Melanoma)

  Friedlander, P.

  8/06/23

  1 item of Media coverage

  Press/Media

• Mount Sinai Researchers Discover How to Boost Efficacy of Vaccine Designed to Prevent Melanoma Recurrence.

  Friedlander, P. & Bhardwaj, N.

  16/11/20 → 18/11/20

  3 items of Media coverage

  Press/Media

• Boost the Melanoma Recurrence prevention Vaccine This Way

  Friedlander, P. & Bhardwaj, N.

  18/11/20

  1 item of Media coverage

  Press/Media

• Mount Sinai Researchers Discover How to Boost Efficacy of...

  Friedlander, P. & Bhardwaj, N.

  17/11/20

  2 items of Media coverage

  Press/Media

• Immune-Boosting Components Double the Effectiveness of Melanoma Vaccine Candidate in Phase II Trial

  Friedlander, P. & Bhardwaj, N.

  17/11/20

  1 item of Media coverage

  Press/Media

• Researchers discover how to boost vaccine designed to prevent melanoma recurrence

  Friedlander, P. & Bhardwaj, N.

  17/11/20

  1 item of Media coverage

  Press/Media

• Mount Sinai Researchers Discover How to Boost Efficacy of Vaccine...

  Friedlander, P. & Bhardwaj, N.

  16/11/20

  14 items of Media coverage

  Press/Media

• Vaccine for Skin Cancer Shows Promise

  Friedlander, P. & Bhardwaj, N.

  16/11/20

  1 item of Media coverage

  Press/Media

• Mount Sinai Researchers Discover How to Boost Efficacy of Vaccine Designed to Prevent Melanoma Recurrence

  Friedlander, P. & Bhardwaj, N.

  16/11/20

  1 item of Media coverage

  Press/Media

• Clinical Trial: Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors

  Friedlander, P.

  5/11/20

  2 items of Media coverage

  Press/Media

• 'Truly Amazing': Huge Change in Melanoma Prognosis

  Friedlander, P.

  25/10/19

  2 items of Media coverage

  Press/Media

• Metastatic Melanoma: What a Change in Prognosis

  Friedlander, P.

  24/10/19

  1 item of Media coverage

  Press/Media